Published in BMC Cardiovasc Disord on February 23, 2012
Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet (2003) 19.90
Myocardial reperfusion injury. N Engl J Med (2007) 13.41
Time delay to treatment and mortality in primary angioplasty for acute myocardial infarction: every minute of delay counts. Circulation (2004) 6.34
Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction. JAMA (2000) 6.00
The wavefront phenomenon of ischemic cell death. 1. Myocardial infarct size vs duration of coronary occlusion in dogs. Circulation (1977) 5.67
Effect of door-to-balloon time on mortality in patients with ST-segment elevation myocardial infarction. J Am Coll Cardiol (2006) 4.11
Symptom-onset-to-balloon time and mortality in patients with acute myocardial infarction treated by primary angioplasty. J Am Coll Cardiol (2003) 2.66
Effect of cyclosporine on left ventricular remodeling after reperfused myocardial infarction. J Am Coll Cardiol (2010) 2.54
System delay and mortality among patients with STEMI treated with primary percutaneous coronary intervention. JAMA (2010) 2.53
Normal flow (TIMI-3) before mechanical reperfusion therapy is an independent determinant of survival in acute myocardial infarction: analysis from the primary angioplasty in myocardial infarction trials. Circulation (2001) 2.43
Abciximab as adjunctive therapy to reperfusion in acute ST-segment elevation myocardial infarction: a meta-analysis of randomized trials. JAMA (2005) 2.26
Impact of primary coronary angioplasty delay on myocardial salvage, infarct size, and microvascular damage in patients with ST-segment elevation myocardial infarction: insight from cardiovascular magnetic resonance. J Am Coll Cardiol (2009) 2.24
Therapy-dependent influence of time-to-treatment interval on myocardial salvage in patients with acute myocardial infarction treated with coronary artery stenting or thrombolysis. Circulation (2003) 1.97
Automated quantification of myocardial infarction from MR images by accounting for partial volume effects: animal, phantom, and human study. Radiology (2007) 1.82
Influence of treatment delay on infarct size and clinical outcome in patients with acute myocardial infarction treated with primary angioplasty. J Am Coll Cardiol (1998) 1.77
Randomized early versus late abciximab in acute myocardial infarction treated with primary coronary intervention (RELAx-AMI Trial). J Am Coll Cardiol (2007) 1.53
Pexelizumab and infarct size in patients with acute myocardial infarction undergoing primary percutaneous coronary Intervention: a delayed enhancement cardiac magnetic resonance substudy from the APEX-AMI trial. JACC Cardiovasc Imaging (2010) 1.47
Duration of ischemia is a major determinant of transmurality and severe microvascular obstruction after primary angioplasty: a study performed with contrast-enhanced magnetic resonance. J Am Coll Cardiol (2005) 1.42
Importance of time to reperfusion for 30-day and late survival and recovery of left ventricular function after primary angioplasty for acute myocardial infarction. J Am Coll Cardiol (1998) 1.39
Infarct evolution in man studied in patients with first-time coronary occlusion in comparison to different species - implications for assessment of myocardial salvage. J Cardiovasc Magn Reson (2009) 1.25
Predictors of infarct size after primary coronary angioplasty in acute myocardial infarction from pooled analysis from four contemporary trials. Am J Cardiol (2007) 1.14
Relationship between size of myocardial infarctions assessed by delayed contrast-enhanced MRI after primary PCI, biochemical markers, and time to intervention. J Interv Cardiol (2004) 1.14
Effect of cigarette smoking on outcome after thrombolytic therapy for myocardial infarction. Circulation (1995) 1.14
Impact of treatment delays on outcomes of primary percutaneous coronary intervention for acute myocardial infarction: analysis from the CADILLAC trial. Am Heart J (2006) 1.12
Time to therapy and salvage in myocardial infarction. J Am Coll Cardiol (1998) 1.09
Correspondence between left ventricular 17 myocardial segments and coronary arteries. Eur Heart J (2005) 1.07
Effects of primary angioplasty for acute myocardial infarction on early and late infarct size and left ventricular wall characteristics. J Am Coll Cardiol (2005) 1.04
Impact of time to treatment on myocardial reperfusion and infarct size with primary percutaneous coronary intervention for acute myocardial infarction (from the EMERALD Trial). Am J Cardiol (2007) 1.04
Influence of time-to-treatment, TIMI-flow grades, and ST-segment resolution on infarct size and infarct transmurality as assessed by delayed enhancement magnetic resonance imaging. Eur Heart J (2007) 0.92
Relationship between residual blood flow in the infarct-related artery and scintigraphic infarct size, myocardial salvage, and functional recovery in patients with acute myocardial infarction. J Nucl Med (2005) 0.85
Reperfusion after primary angioplasty for ST-elevation myocardial infarction: predictors of success and relationship to clinical outcomes in the APEX-AMI angiographic study. Eur Heart J (2008) 0.83
Spontaneous reperfusion in ST-elevation myocardial infarction: comparison of angiographic and electrocardiographic assessments. Am Heart J (2008) 0.83
Late improvement of regional wall motion after the subacute phase of myocardial infarction treated by acute PTCA in a 6-month follow-up. J Cardiovasc Magn Reson (2003) 0.80
Early treatment with abciximab in patients with ST elevation myocardial infarction results in a high rate of normal or near normal blood flow in the infarct related artery. Acute Card Care (2010) 0.77
Benefit of angiographic spontaneous reperfusion in STEMI: does it extend to diabetic patients? Heart (2009) 0.77
Patent coronary artery and myocardial infarction in the era of primary angioplasty: assessment of an old problem in a new setting with data from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR). EuroIntervention (2010) 0.77
Prehospital ticagrelor in ST-segment elevation myocardial infarction. N Engl J Med (2014) 5.25
5-year outcomes in the FRISC-II randomised trial of an invasive versus a non-invasive strategy in non-ST-elevation acute coronary syndrome: a follow-up study. Lancet (2006) 3.01
A long-term perspective on the protective effects of an early invasive strategy in unstable coronary artery disease: two-year follow-up of the FRISC-II invasive study. J Am Coll Cardiol (2002) 2.87
Semi-automatic quantification of myocardial infarction from delayed contrast enhanced magnetic resonance imaging. Scand Cardiovasc J (2005) 2.42
Cost-effectiveness of treating acute coronary syndrome patients with ticagrelor for 12 months: results from the PLATO study. Eur Heart J (2012) 2.16
Transit of blood flow through the human left ventricle mapped by cardiovascular magnetic resonance. J Cardiovasc Magn Reson (2007) 1.75
Invasive treatment in unstable coronary artery disease promotes health-related quality of life: results from the FRISC II trial. Am Heart J (2004) 1.68
Early measurements of plasma matrix metalloproteinase-2 predict infarct size and ventricular dysfunction in ST-elevation myocardial infarction. Heart (2011) 1.65
Early abciximab use in ST-elevation myocardial infarction treated with primary percutaneous coronary intervention improves long-term outcome. Data from EUROTRANSFER Registry. Kardiol Pol (2010) 1.54
Semi-automatic quantification of 4D left ventricular blood flow. J Cardiovasc Magn Reson (2010) 1.51
Functional measurements based on feature tracking of cine magnetic resonance images identify left ventricular segments with myocardial scar. Cardiovasc Ultrasound (2009) 1.50
Health-related quality of life of ticagrelor versus clopidogrel in patients with acute coronary syndromes-results from the PLATO trial. Value Health (2013) 1.45
Quantitative T-wave analysis predicts 1 year prognosis and benefit from early invasive treatment in the FRISC II study population. Eur Heart J (2004) 1.44
Differences in recovery of left and right ventricular function following aortic valve interventions: a longitudinal echocardiographic study in patients undergoing surgical, transapical or transfemoral aortic valve implantation. Catheter Cardiovasc Interv (2013) 1.41
Impact of infarct related artery patency after early abciximab administration on one-year mortality in patients with ST-segment elevation myocardial infarction (data from the EUROTRANSFER Registry). Kardiol Pol (2012) 1.39
Frailty is independently associated with short-term outcomes for elderly patients with non-ST-segment elevation myocardial infarction. Circulation (2011) 1.39
Cost-effectiveness of dabigatran compared with warfarin for patients with atrial fibrillation in Sweden. Eur Heart J (2012) 1.29
Time trends in STEMI--improved treatment and outcome but still a gender gap: a prospective observational cohort study from the SWEDEHEART register. BMJ Open (2012) 1.26
Assessment of fluctuating velocities in disturbed cardiovascular blood flow: in vivo feasibility of generalized phase-contrast MRI. J Magn Reson Imaging (2008) 1.25
Gender differences in management and outcome in non-ST-elevation acute coronary syndrome. Heart (2006) 1.22
Flow patterns in the aortic root and the aorta studied with time-resolved, 3-dimensional, phase-contrast magnetic resonance imaging: implications for aortic valve-sparing surgery. J Thorac Cardiovasc Surg (2004) 1.21
Quantification of presystolic blood flow organization and energetics in the human left ventricle. Am J Physiol Heart Circ Physiol (2011) 1.17
Rapid T1 quantification based on 3D phase sensitive inversion recovery. BMC Med Imaging (2010) 1.03
A gender perspective on short- and long term mortality in ST-elevation myocardial infarction--a report from the SWEDEHEART register. Int J Cardiol (2012) 1.00
Gender perspective on risk factors, coronary lesions and long-term outcome in young patients with ST-elevation myocardial infarction. Heart (2010) 1.00
Impact of female sex on death and bleeding after fibrinolytic treatment of myocardial infarction in GUSTO V. Arch Intern Med (2007) 0.98
How to set up an effective national primary angioplasty network: lessons learned from five European countries. EuroIntervention (2009) 0.96
Factors related to delay times in patients with suspected acute myocardial infarction. Heart Lung (2004) 0.95
Soluble TNF receptors are associated with infarct size and ventricular dysfunction in ST-elevation myocardial infarction. PLoS One (2013) 0.93
Low molecular weight heparin (dalteparin) compared to unfractionated heparin as an adjunct to rt-PA (alteplase) for improvement of coronary artery patency in acute myocardial infarction-the ASSENT Plus study. Eur Heart J (2003) 0.92
Outcome of ST-elevation myocardial infarction treated with thrombolysis in the unselected population is vastly different from samples of eligible patients in a large-scale clinical trial. Am Heart J (2004) 0.91
Wolff-Parkinson-White syndrome and atrioventricular nodal re-entry tachycardia in a Swedish population: consequences on health-related quality of life. Pacing Clin Electrophysiol (2009) 0.90
Ambulance use in patients with acute myocardial infarction. J Cardiovasc Nurs (2004) 0.88
Evaluation of right and left ventricular function using speckle tracking echocardiography in patients with arrhythmogenic right ventricular cardiomyopathy and their first degree relatives. Cardiovasc Ultrasound (2012) 0.88
A gender perspective on sleeplessness behavior, effects of sleep loss, and coping resources in patients with stable coronary artery disease. Heart Lung (2006) 0.87
Three-directional myocardial motion assessed using 3D phase contrast MRI. J Cardiovasc Magn Reson (2004) 0.87
Manageability, vulnerability and interaction: a qualitative analysis of acute myocardial infarction patients' conceptions of the event. Eur J Cardiovasc Nurs (2006) 0.87
Artificial neural network algorithms for early diagnosis of acute myocardial infarction and prediction of infarct size in chest pain patients. Int J Cardiol (2006) 0.86
European registry on patients with ST-elevation myocardial infarction transferred for mechanical reperfusion with a special focus on early administration of abciximab -- EUROTRANSFER Registry. Am Heart J (2008) 0.86
NK cell apoptosis in coronary artery disease: relation to oxidative stress. Atherosclerosis (2008) 0.86
Determining optimal noninvasive parameters for the prediction of left ventricular remodeling in chronic ischemic patients. Scand Cardiovasc J (2013) 0.85
Compilation of cost-effectiveness evidence for different heart conditions and treatment strategies. Scand Cardiovasc J (2011) 0.85
Point-of-Care Troponin T Testing in the Management of Patients with Chest Pain in the Swedish Primary Care. Int J Family Med (2013) 0.85
Left ventricular function and cardiovascular events following adjuvant therapy with adenosine in acute myocardial infarction treated with thrombolysis, results of the ATTenuation by Adenosine of Cardiac Complications (ATTACC) study. Eur J Clin Pharmacol (2003) 0.85
Simultaneous three-dimensional myocardial T1 and T2 mapping in one breath hold with 3D-QALAS. J Cardiovasc Magn Reson (2014) 0.84
Myeloperoxidase is not useful for the early assessment of patients with chest pain. Clin Biochem (2009) 0.84
Hemodynamic aspects of mitral regurgitation assessed by generalized phase-contrast MRI. J Magn Reson Imaging (2011) 0.84
An invasive or conservative strategy in patients with diabetes mellitus and non-ST-segment elevation acute coronary syndromes: a collaborative meta-analysis of randomized trials. J Am Coll Cardiol (2012) 0.83
Cost consequences of point-of-care troponin T testing in a Swedish primary health care setting. Scand J Prim Health Care (2014) 0.82
Improved estimation and visualization of two-dimensional myocardial strain rate using MR velocity mapping. J Magn Reson Imaging (2008) 0.82
Noninvasive assessment of coronary vasodilation using cardiovascular magnetic resonance in patients at high risk for coronary artery disease. J Cardiovasc Magn Reson (2008) 0.81
Strategies TO reduce time delays in patients with AcuTe coronary heart disease treated with primary PCI--the STOP WATCH study: a multistage action research project. BMJ Open (2013) 0.81
Early invasive compared with a selective invasive strategy in women with non-ST-elevation acute coronary syndromes: a substudy of the OASIS 5 trial and a meta-analysis of previous randomized trials. Eur Heart J (2009) 0.81
Thirst response to acute hypovolaemia in healthy women and women prone to vasovagal syncope. Physiol Behav (2013) 0.80
Left and right ventricular function in aortic stenosis patients 8 weeks post-transcatheter aortic valve implantation or surgical aortic valve replacement. Eur J Echocardiogr (2011) 0.80
Dynamic real-time architecture in magnetic resonance coronary angiography--a prospective clinical trial. J Cardiovasc Magn Reson (2004) 0.80
Stable or not, woman or man: is there a difference? Eur Heart J (2012) 0.80
Feasibility and diagnostic power of transthoracic coronary Doppler for coronary flow velocity reserve in patients referred for myocardial perfusion imaging. Cardiovasc Ultrasound (2008) 0.80
Early abciximab administration before primary percutaneous coronary intervention improves clinical outcome in elderly patients transferred with ST-elevation myocardial infarction: data from the EUROTRANSFER registry. Int J Cardiol (2009) 0.79
Circadian blood pressure variation in patients with type 2 diabetes--relationship to macro- and microvascular subclinical organ damage. Prim Care Diabetes (2011) 0.79
Numerical and experimental assessment of turbulent kinetic energy in an aortic coarctation. J Biomech (2013) 0.79
Cardiovascular risk factors related to the PPARγ Pro12Ala polymorphism in patients with type 2 diabetes are gender dependent. Blood Press (2011) 0.78
Novel plakophilin2 mutation: three-generation family with arrhythmogenic right ventricular cardiomyopathy. Scand Cardiovasc J (2011) 0.78
Although women are less likely to be admitted to coronary care units, they are treated equally to men and have better outcome. A prospective cohort study in patients with non ST-elevation acute coronary syndromes. Acute Card Care (2009) 0.78
Hyperarousal, depression and quality of life--validity and reliability of the Swedish version of the Hyperarousal Scale. Scand J Caring Sci (2006) 0.78
Risk prediction in chest pain patients by biochemical markers including estimates of renal function. Int J Cardiol (2007) 0.77
Computer-assisted calculation of myocardial infarct size shortens the evaluation time of contrast-enhanced cardiac MRI. Clin Physiol Funct Imaging (2007) 0.77
Myocardial strains from 3D displacement encoded magnetic resonance imaging. BMC Med Imaging (2012) 0.77
Early treatment with abciximab in patients with ST elevation myocardial infarction results in a high rate of normal or near normal blood flow in the infarct related artery. Acute Card Care (2010) 0.77
Management of acute coronary syndromes from a gender perspective. Fundam Clin Pharmacol (2010) 0.77
Educational needs in adults with congenitally malformed hearts. Cardiol Young (2008) 0.76
Recurrence of myxoma in the left ventricle with concurrent cerebral fusiform aneurysms after previous atrial myxoma surgery. J Thorac Cardiovasc Surg (2008) 0.76
Early abciximab administration before primary percutaneous coronary intervention improves clinical outcome in diabetic patients with ST-segment elevation myocardial infarction (EUROTRANSFER Registry). Atherosclerosis (2012) 0.76
Safety profile and tolerability of intravenous AR-C69931MX, a new antiplatelet drug, in unstable angina pectoris and non-Q-wave myocardial infarction. Clin Ther (2002) 0.76
Ambulatory systolic blood pressure predicts left ventricular mass in type 2 diabetes, independent of central systolic blood pressure. Blood Press Monit (2012) 0.76
Influence of the FID and off-resonance effects in dense MRI. Magn Reson Med (2010) 0.75
Sleep, arousal and health-related quality of life in men and women with coronary artery disease. J Clin Nurs (2011) 0.75
Description and initial evaluation of an educational and psychosocial support model for adults with congenitally malformed hearts. Patient Educ Couns (2010) 0.75
[Coronary computer tomography--time for reflection. A survey of the current knowledge]. Lakartidningen (2009) 0.75
Fully automatic left ventricular myocardial strain estimation in 2D short-axis tagged magnetic resonance imaging. Phys Med Biol (2017) 0.75